Exploring the Potential of Direct-To-Consumer Genomic Test Data for Predicting Adverse Drug Events

Ítems similars

• Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
  per: Brown, Joshua D., et al.
  Publicat: (2019)
• Predicting potential adverse events using safety data from marketed drugs
  per: Daluwatte, Chathuri, et al.
  Publicat: (2020)
• Drug-induced adverse events prediction with the LINCS L1000 data
  per: Wang, Zichen, et al.
  Publicat: (2016)
• Low budget analysis of Direct-To-Consumer genomic testing familial data
  per: Glusman, Gustavo, et al.
  Publicat: (2012)
• Exploring adverse drug events at the class level
  per: Winnenburg, Rainer, et al.
  Publicat: (2015)